FDA approves Edwards Lifesciences' tissue valve replacement for heart's mitral position

Edwards Lifesciences (NYSE:EW) announced today that the FDA approved its Mitris Resilia tissue valve replacement system.

Related Keywords

Japan ,Canada ,Mitris Resilia ,Edward Mitris Resilia , ,Edwards Lifesciences ,California Based Edwards ,Daveen Chopra ,